Dechert has advised Patria Investments. Patria Investments has announced the final close of its Secondary Opportunities Fund V (SOF V), securing more than US$670 million in...
Patria Investments Announces US$670 Million Final Close for Secondary Opportunities Fund V
Macquarie Asset Management Acquires Spire Partners to Establish European CLO Platform
Dechert has advised Spire Partners on its acquisition by Macquarie Asset Management. Macquarie Asset Management (MAM) has announced the acquisition of Spire Partners (Spire), a transaction...
PlaqueTec Raises $5 Million in Oversubscribed Investment Round
Burges Salmon has advised PlaqueTec Limited. PlaqueTec Limited, a Cambridge-based medtech company specializing in intracoronary liquid biopsy technologies, has completed a $5 million oversubscribed investment fundraise....
Vangest Engineering Solutions and Zeno Partners Acquire UK Medtech Companies
Burges Salmon has advised Vangest Engineering Solutions S.A. and Zeno Partners. Vangest Engineering Solutions S.A., a leading engineering and manufacturing solutions provider based in Portugal and...
Simec Atlantis Energy Secures Investment for Uskmouth Battery Storage Project
Burges Salmon has advised Simec Atlantis Energy Limited. Simec Atlantis Energy Limited (SAE) has secured a landmark investment to develop a 240MWh battery storage facility at...
National Wealth Fund Makes £50 Million Investment in AMP Clean Energy
Burges Salmon has advised National Wealth Fund. National Wealth Fund has completed a £50 million equity investment in AMP Clean Energy, marking a significant effort to...
£59.6 Million Joint Venture Formed for Peak Cluster Decarbonisation Project
Burges Salmon has advised Peak Cluster. A joint venture has been established as part of the Peak Cluster decarbonisation initiative, representing a transaction valued at £59.6...
Schenk Tanktransport’s Acquisition Of Suttons Tankers
Burges Salmon advised Schenk Tanktransport on the deal. Schenk Tanktransport, a leading tank transport company in Northwest Europe, acquired Suttons Tankers, a well-established UK road tanker...
Calcivis’ £5 Million Funding Round
The Burges Salmon team advised Calcivis on the deal. Calcivis, a Scottish biotech that aims to revolutionise early-intervention diagnostics in dentistry, completed its £5 million investment....
Cumulus Oncology’s £9 Million Seed Funding Round
Burges Salmon advised cancer therapeutics company Cumulus Oncology Limited on the deal. Cumulus Oncology Limited completed a £9 million funding package secured from the Scottish National Investment Bank...
Cytomos’ £4 Million Funding Round
Burges Salmon advises life sciences company Cytomos on £4m funding. The Corporate Group at independent UK law firm Burges Salmon has advised Cytomos, an Edinburgh-based life...
Nodus Oncology’s Acquisition of IP Assets From Basilea Pharmaceutica International AG
Burges Salmon advised biotech company Nodus Oncology on the deal. Nodus Oncology, a novel biotech company, on its strategic acquisition of certain oncology based IP assets...